Cormac P Cosgrove

5PUBLICATIONS
37CO-AUTHORS
Gene and molecular therapyMolecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 28, 2025
ABBV-303 Is an NK-cell Engager Specific for c-Met-Expressing Tumors.

Jennifer D Stone, Kamonwan Fish, Devika Ashok

|Jun 09, 2023
ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic Malignancies.

Adam S Chervin, Jennifer D Stone, Iwona Konieczna

|Feb 21, 2020
Adoptive T-Cell Transfer to Treat Lymphangioleiomyomatosis.

Fei Han, Emilia R Dellacecca, Levi W Barse

|Jul 17, 2018
Molecular properties of gp100-reactive T-cell receptors drive the cytokine profile and antitumor efficacy of transgenic host T cells.

Jonathan M Eby, Angela R Smith, Timothy P Riley

|May 17, 2018
Poorly cytotoxic terminally differentiated CD56<sup>neg</sup>CD16<sup>pos</sup> NK cells accumulate in Kenyan children with Burkitt lymphomas.

Catherine S Forconi, Cormac P Cosgrove, Pryia Saikumar-Lakshmi

Pageof 1

Frequent Collaborators

2 joint publications

I Caroline Le Poole

2 joint publications

Edward B Reilly

2 joint publications

Adam S Chervin

2 joint publications

Jennifer D Stone